The Case is Made for New CPT Codes
The Challenge
A ground-breaking medical device, although recognized by major clinical compendia, was lacking the appropriate Current Procedural Terminology (CPT) codes. This created hesitancy among providers, who feared they would not be reimbursed or prescribing this supportive care technology for their patients.
The IP Solution
IP developed and executed a multi-pronged strategy to support the approval of a CPT code for the medical device.
As a key first step, our team worked closely with the manufacturer to author and submit an article to a peer-reviewed publication. It addressed the importance of the work and direct involvement needed on the part of physicians, to support the use of the device.
Following the publication of the article, our team delivered the guidance and support needed to submit an application to the American Medical Association (AMA) for a new CPT code.
Additionally, we engaged influential physicians and thought leaders within the supportive care space to advocate for the product and create awareness among providers and patients.
IP continues to be critical in our US strategy. From day one they have worked closely with [us] as an extended part of our company, understanding our challenges and working with us to find solutions putting a clear strategy in place and ultimately delivering on their word. Our relationship is incredibly strong.
The Results
Months of persistence paid off and the AMA accepted the company’s application for a Category III CPT Code, a significant step to ensure access for cancer and chemotherapy patients across the US. IP has continued to provide support in crafting a communication strategy to ensure there is substantial awareness of the new code and reimbursement options for practices across the country.
